等待開盤 06-25 09:30:00 美东时间
+0.440
+0.39%
Appointment of seasoned innovator reinforces the company's leadership at the intersection of hospitality, data, AI, and technology NORTH BETHESDA, Md., June 8, 2026 /PRNewswire/ -- Choice Ho...
06-08 21:00
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
Patrick Pacious Steps Down as President and Chief Executive Officer Chief Growth & Strategy Officer Dominic Dragisich Appointed Interim Chief Executive Officer Company Reaffirms Full Year 20...
05-21 04:05
Shares of companies in the broader consumer discretionary sector are trading hi...
05-21 02:03
别光看球!这份2026世界杯概念股最全名单,基建、酒店、旅游都在内,赶紧收藏>>
05-20 20:34
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Morgan Stanley analyst Stephen Grambling maintains Choice Hotels Intl (NYSE:CHH) with a Underweight and lowers the price target from $87 to $86.
05-13 00:30
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04